Recently, NEEQ (National Equities Exchange and Quotations) notice shows that Hefei Sunshine Medical Technology Co., Ltd was approved to list on the new OTC market and public transfer.

Hefei Sunshine Medical Technology Co., Ltd was established in April 27, 1999.It’s a high-tech enterprise with medical industrial investment, software development, instrument development, medical electronic equipment maintenance, in vitro diagnostic reagents and accessory equipment quality control calibrators’ sales and service. Clients are mostly all types of hospitals, centers for disease control, clinical Centre, the blood center, an independent commercial laboratories, research institutes of biological testing laboratories in Anhui Province. Main business is through its own system of integrated services to all categories of medical laboratories (mainly for the clinical laboratory of hospital) provide comprehensive services of in vitro diagnostic products and professional technical support.

Date shows Hefei Sunshine’s main IVD products are major domestic and foreign brands of diagnostic reagents, diagnostic equipment and medical supplies, including biochemical, immune, blood fat, blood cell, blood coagulation, urinalysis, HBV, myocardium, and other product types, covering the most test projects in hospital.

The financial results shows,  the revenues for Hefei Sunshine in 2014 and 2015 are ￥30.68 million and ￥35.89 million, the net profit are 1.04 million and 2.53million.